Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy

Expression of androgen receptor (AR) splice variant 7 (AR-V7) has been identified as the mechanism associated with the development of castration-resistant prostate cancer (CRPC). However, a potential link between AR-V7 expression and resistance to taxanes, such as docetaxel or cabazitaxel, has not b...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Med
Auteurs principaux: Shimizu, Yasuomi, Tamada, Satoshi, Kato, Minoru, Hirayama, Yukiyoshi, Takeyama, Yuji, Iguchi, Taro, Sadar, Marianne D., Nakatani, Tatsuya
Format: Artigo
Langue:Inglês
Publié: MDPI 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6262607/
https://ncbi.nlm.nih.gov/pubmed/30453546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm7110444
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires